Tactile Medical Q4 rev $85.6M (+10%), net income $9.7M; guides FY25 rev $316-322M

TACTILE SYSTEMS TECHNOLOGY INC

2024-FY EPS reported $0.70 revenue$292,984,000

Q4 total revenue $85.6M (+10% YoY); gross margin 75.2% vs 72.1% YoY.
Q4 net income $9.7M ($0.40 diluted EPS) vs $8.2M ($0.35) YoY.
FY2024 revenue $293.0M (+7%); net income $17.0M vs $28.5M in 2023.
Cash $94.4M at year-end, up from $61.0M; $26.5M remaining share repurchase authorization.
FY2025 revenue guidance $316-322M (8-10% growth); adjusted EBITDA $35-37M vs $37.1M in 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.